|
Volumn 32, Issue SUPPL. 1, 2002, Pages 29-32
|
Economic impact of treating inhibitor patients
|
Author keywords
Cost; Inhibitors; QALY; rFVIIa
|
Indexed keywords
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
ALLOANTIBODY;
BLOOD CLOTTING FACTOR;
BLOOD CLOTTING FACTOR 7;
RECOMBINANT FVIIA;
RECOMBINANT PROTEIN;
BLEEDING;
CONFERENCE PAPER;
ECONOMICS;
HEALTH CARE SYSTEM;
HEMOPHILIA;
PAIN;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REIMBURSEMENT;
BLOOD;
COST BENEFIT ANALYSIS;
DISEASE MANAGEMENT;
HEMOPHILIA A;
HUMAN;
IMMUNOLOGY;
QUALITY ADJUSTED LIFE YEAR;
REVIEW;
BLOOD COAGULATION FACTORS;
COST-BENEFIT ANALYSIS;
DISEASE MANAGEMENT;
FACTOR VII;
HEMOPHILIA A;
HUMANS;
ISOANTIBODIES;
QUALITY-ADJUSTED LIFE YEARS;
RECOMBINANT PROTEINS;
|
EID: 1042287913
PISSN: 14248832
EISSN: None
Source Type: Journal
DOI: 10.1159/000057298 Document Type: Conference Paper |
Times cited : (11)
|
References (10)
|